About Jim Qiu

Jim Qiu is an equity partner and co-leader of Zhong Lun’s pharmaceuticals and life sciences practice group. Jim serves numerous multinational and domestic healthcare organisations, including biotechnology, pharmaceutical companies, medical device companies, online and third-party medical service providers, healthcare institutions, and industry associations. His practice encompasses the complete operational lifecycle of healthcare and life science enterprises, including industry access, licensing transactions, R&D compliance, regulatory matters, product marketing, healthcare professional interactions, pharmacovigilance, adverse event reporting, digital health and medical malpractice.

Contributions to Global Practice Guides

Healthcare M&A Trends and Developments in China

Healthcare M&A Law and Practice in China

}

Chambers and Partners make no representation or endorsement of the quality and services supplied by companies or firms that may be found on this website. In no event will Chambers and Partners be liable for any damages including, without limitation, indirect or consequential damages, or any damages whatsoever arising from use or loss of use, data, or profits, whether in action of contract, negligence or other tort action, arising out of or in connection with the use of the website.